2024 Research Leaders: Leading corporate institutions in biological sciences

The 2024 Research Leaders are based on Nature Index data from 1 January 2023 to 31 December 2023.

Table criteria

# Institution Share 2022 Share 2023 Count 2023 Change in Adjusted Share* 2022–2023
1 BGI, China 12.78 8.30 52 -27.6% Decrease
2 Formosa Plastics Group, Taiwan 6.12 2.94 19 -46.3% Decrease
3 Huigene Therapeutics Inc., China 0.16 2.69 4 1,793.4% Increase
4 Daiichi Sankyo Co., Ltd., Japan 1.28 1.97 7 72.1% Increase
5 Tencent, China 0.65 1.73 13 195.7% Increase
6 Samsung Group, South Korea 0.80 1.63 20 125.4% Increase
7 Mitsubishi Group, Japan 0.14 1.53 7 1,126.0% Increase
8 Otsuka Holdings Co., Ltd., Japan 0.31 1.25 6 355.0% Increase
9 Qi Biodesign, China 0.00 1.19 5 0.0% Increase
10 Nippon Telegraph and Telephone Corporation (NTT), Japan 1.83 1.09 3 -33.7% Decrease
11 National Institute of Water and Atmospheric Research Ltd. (NIWA), New Zealand 0.31 1.03 7 277.3% Increase
12 Alibaba Group Holding Limited, China 0.47 1.03 14 144.9% Increase
13 QL Biopharmaceutical Technology Co., Ltd., China 0.02 1.00 1 5,250.9% Increase
14 China State Shipbuilding Corporation Limited (CSSC), China 1.53 0.98 38 -28.7% Decrease
15 TIPR Pharmaceutical Co., Ltd., China 0.59 0.96 17 81.3% Increase
16 The Australian Wine Research Institute (AWRI), Australia 1.06 0.92 1 -3.8% Decrease
17 GeneMind Biosciences Company Limited, China 0.00 0.90 2 0.0% Increase
18 Hua Medicine (Shanghai) Co., Ltd., China 0.10 0.90 1 863.1% Increase
19 Astellas Pharma Inc., Japan 0.23 0.89 4 329.8% Increase
20 Takeda Pharmaceutical Company Limited, Japan 2.09 0.86 9 -54.4% Decrease
21 The New Zealand Institute for Plant and Food Research Ltd., New Zealand 1.10 0.84 12 -15.0% Decrease
22 Biofusion Therapeutics Limited, India 0.00 0.80 1 0.0% Increase
23 Yuan Long Ping High-Tech Agriculture CO., LTD. (LPHT), China 0.01 0.73 5 9,413.6% Increase
24 PharmAbcine Inc., South Korea 0.00 0.73 1 0.0% Increase
25 Wuxi Biortus Biosciences Co., Ltd., China 0.38 0.63 1 83.6% Increase
26 Topchoice Group, China 0.31 0.61 7 116.4% Increase
27 Genomics Bioscience and Technology Co Ltd., Taiwan 0.00 0.58 2 0.0% Increase
28 China National Chemical Corporation (ChemChina), China 1.44 0.58 5 -55.1% Decrease
29 Stemirna Therapeutics Co., Ltd., China 0.00 0.56 1 0.0% Increase
30 Burning Rock Biotech Ltd., China 0.00 0.56 2 0.0% Increase
31 Huahui Health Ltd., China 0.00 0.55 1 0.0% Increase
32 Shimadzu Corporation, Japan 0.05 0.55 4 1,198.8% Increase
33 ADEL Inc., South Korea 0.00 0.54 2 0.0% Increase
34 GrandOmics Biosciences, China 0.32 0.54 4 89.2% Increase
35 Simcere Pharmaceutical Group, China 0.15 0.53 3 283.9% Increase
36 Multitude Therapeutics Ltd., China 0.00 0.50 1 0.0% Increase
36 Beijing Syngentech Co., LTD., China 0.00 0.50 1 0.0% Increase
36 Ceres, Inc., Japan 0.00 0.50 1 0.0% Increase
37 Nan Fung Group, China 0.00 0.47 1 0.0% Increase
38 National Chengdu Center for Safety Evaluation of Drugs, China 0.06 0.45 2 688.7% Increase
39 Sumitomo Dainippon Pharma Co., Ltd., Japan 0.00 0.44 1 0.0% Increase
39 Sumitomo Pharma Co., Ltd., Japan 0.29 0.44 2 73.6% Increase
40 Sinocelltech Ltd., China 0.00 0.43 1 0.0% Increase
41 Guangdong Wens Foodstuff Group Co., Ltd., China 0.00 0.43 2 0.0% Increase
42 Innovent Biologics, Inc., China 1.76 0.42 2 -73.2% Decrease
43 Syneron Technology, China 0.00 0.42 3 0.0% Increase
44 Centre for Oncology and Immunology Limited, China 0.35 0.41 5 29.4% Increase
45 Novogene Co., Ltd., China 0.46 0.41 7 -0.4% Decrease
46 GeneX Health Co., Ltd., China 0.13 0.41 1 264.8% Increase
47 Exopert Corporation, South Korea 0.00 0.41 1 0.0% Increase

Footnote

Each year, the Nature Index publishes tables based on counts of high-quality research outputs in the previous calendar year. Users please note:

  1. The data behind the tables are based on a relatively small proportion of total research papers, they cover the natural sciences and health sciences only and outputs are non-normalized (that is, they don’t reflect the size of the country or institution, or its overall research output).
  2. The Nature Index is one indicator of institutional research performance. The metrics of Count and Share used to order Nature Index listings are based on an institution’s or country’s publication output in 145 natural-science and health-science journals. The journals were selected on reputation by an independent panel of leading scientists in their fields. The list is reviewed periodically and journals may be removed or added. Articles from eLife were no longer included in the Nature Index from 2023 after the journal changed its publishing model.
  3. Nature Index recognizes that many other factors must be taken into account when considering research quality and institutional performance; Nature Index metrics alone should not be used to assess institutions or individuals.
  4. Nature Index data and methods are transparent and available under a creative commons licence at nature.com/nature-index/.
  5. Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

The Nature Index database undergoes regular updating, corrections, adjustment of institutional hierarchies, and removal of retracted papers and thus the live website can differ from the frozen research leaders.